Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma
NCT02329717
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DRUG:
PBI 05204
Sponsor
Phoenix Biotechnology, Inc